IDXX IDEXX Laboratories, Inc. Stock Quote

IDXX [NASD]

Healthcare | Diagnostics & Research | USA

Index	S&P 500	P/E	79.42	EPS (ttm)	6.71	Insider Own	0.90%	Shs Outstand	85.49M	Perf Week	-1.38%
Market Cap	46.16B	Forward P/E	61.67	EPS next Y	8.64	Insider Trans	-19.89%	Shs Float	84.53M	Perf Month	8.93%
Income	581.80M	PEG	4.65	EPS next Q	1.70	Inst Own	88.20%	Short Float	0.95%	Perf Quarter	14.77%
Sales	2.71B	P/S	17.06	EPS this Y	37.30%	Inst Trans	-0.02%	Short Ratio	1.88	Perf Half Y	40.00%
Book/sh	7.39	P/B	72.11	EPS next Y	15.11%	ROA	28.40%	Target Price	549.17	Perf Year	107.58%
Cash/sh	4.43	P/C	120.25	EPS next 5Y	17.09%	ROE	160.10%	52W Range	168.65 - 573.99	Perf YTD	6.60%
Dividend	-	P/FCF	85.31	EPS past 5Y	26.70%	ROI	39.90%	52W High	-7.16%	Beta	0.91
Dividend %	-	Quick Ratio	1.50	Sales past 5Y	11.10%	Gross Margin	58.00%	52W Low	215.97%	ATR	18.17
Employees	9300	Current Ratio	1.80	Sales Q/Q	19.10%	Oper. Margin	25.70%	RSI (14)	58.01	Volatility	4.45% 3.70%
Optionable	Yes	Debt/Eq	1.44	EPS Q/Q	93.80%	Profit Margin	21.50%	Rel Volume	1.03	Prev Close	525.22
Shortable	Yes	LT Debt/Eq	1.36	Earnings	Feb 02 BMO	Payout	0.00%	Avg Volume	426.78K	Price	532.88
Recom	1.90	SMA20	4.37%	SMA50	7.18%	SMA200	31.07%	Volume	439,684	Change	1.46%

Feb-17-21

Initiated

Barclays

Overweight

$600

Sep-09-19

Initiated

Goldman

Neutral

$277

May-23-19

Initiated

Guggenheim

Buy

$276

Nov-02-18

Reiterated

BofA/Merrill

Buy

$275 → $235

May-07-18

Reiterated

Stifel

Buy

$215 → $225

Jan-16-18

Initiated

Piper Jaffray

Overweight

$200

Aug-23-17

Upgrade

BofA/Merrill

Neutral → Buy

Jul-28-17

Upgrade

CL King

Neutral → Buy

Feb-03-17

Downgrade

Feltl & Co.

Hold → Sell

Sep-29-16

Resumed

BofA/Merrill

Neutral

Aug-16-16

Reiterated

Stifel

Buy

$120 → $125

Aug-03-16

Upgrade

Northcoast

Sell → Neutral

Jul-20-16

Reiterated

Canaccord Genuity

Buy

$90 → $98

Apr-19-16

Reiterated

Canaccord Genuity

Buy

$80 → $85

Apr-01-16

Initiated

CL King

Neutral

Mar-21-16

Reiterated

Stifel

Buy

$80 → $85

Feb-04-16

Initiated

Credit Suisse

Outperform

Oct-29-15

Reiterated

Stifel

Buy

$85 → $80

Aug-28-15

Downgrade

Raymond James

Outperform → Mkt Perform

Aug-13-15

Reiterated

Stifel

Buy

$78 → $85

Feb-22-21 01:00PM	Veterans Affairs Canada introduces expanded focus for commemoration CNW Group
Feb-21-21 06:30AM	Why This Under-the-Radar Growth Stock Will Be the Top Dog in 2021 Motley Fool
Feb-19-21 07:00AM	Love Your Pets? Buy and Hold This Growth Stock for Life, Too Motley Fool
Feb-16-21 04:30PM	IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences PR Newswire
Feb-12-21 09:19AM	Bio-Rad (BIO) Q4 Earnings Surpass Estimates, Margins Rise Zacks
09:17AM	Illumina (ILMN) Q4 Earnings Top Estimates, Margins Decline Zacks
Feb-11-21 09:55AM	Medtronic's (MDT) Nellcor Favored in Study Over Masimo's Oximetry Zacks
Feb-10-21 10:18AM	QIAGEN (QGEN) Q4 Earnings Beat Estimates, Margins Improve Zacks
Feb-04-21 01:34PM	Cardiovascular Systems (CSII) Posts Break-Even Earnings in Q2 Zacks
08:07AM	Align Technology (ALGN) Beats on Q4 Earnings, Margins Up Zacks
Feb-03-21 11:23AM	The Cooper Companies (COO) Unit Gets a Boost From New Buyout Zacks
Feb-02-21 03:30PM	IDEXX Laboratories Inc (IDXX) Q4 2020 Earnings Call Transcript Motley Fool
01:11PM	IDEXX (IDXX) Earnings Beat Estimates in Q4, Margins Rise Zacks
08:45AM	Why You Should Add AngioDynamics (ANGO) to Your Portfolio Zacks
07:55AM	Idexx Laboratories (IDXX) Beats Q4 Earnings and Revenue Estimates Zacks
07:06AM	Recap: IDEXX Laboratories Q4 Earnings Benzinga
06:30AM	IDEXX Laboratories, Inc. to Host Earnings Call ACCESSWIRE
06:30AM	IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results PR Newswire
Feb-01-21 10:55AM	MedTech Stock Earnings on Feb 2: IDXX, MCK & More Zacks
10:05AM	Earnings Preview for IDEXX Laboratories Benzinga
Jan-29-21 08:45AM	Could IDEXX Laboratories (NASDAQ:IDXX) Multiply In Value? Simply Wall St.
08:33AM	NextGen Healthcare (NXGN) Loses 8.8% Despite Q3 Earnings Beat Zacks
Jan-28-21 01:01PM	Accuray (ARAY) Q2 Earnings and Revenues Surpass Estimates Zacks
12:10PM	ABIOMED (ABMD) Earnings and Revenues Beat Estimates in Q3 Zacks
10:45AM	Stryker (SYK) Q4 Earnings Surpass Estimates, Revenues Miss Zacks
10:43AM	CONMED (CNMD) Q4 Earnings Beat Estimates, Revenues Miss Zacks
07:30AM	IDEXX and the Tuskegee University College of Veterinary Medicine Announce Landmark Initiative PR Newswire
Jan-27-21 11:51AM	Varian (VAR) Q1 Earnings Beat Estimates, Revenues Miss Mark Zacks
09:34AM	What's in Store for IDEXX Laboratories (IDXX) in Q4 Earnings? Zacks
Jan-26-21 12:31PM	Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy? Zacks
Jan-25-21 09:00AM	Leading Global Media Name Slovenia a 'Must Visit' destination for 2021 CNW Group
Jan-23-21 07:01AM	The 3 Best Healthcare Stocks to Buy for 2021 Motley Fool
Jan-22-21 09:55AM	Intuitive Surgical (ISRG) Q4 Earnings Beat Estimates, Up Y/Y Zacks
09:37AM	10 Best Agriculture Technology Stocks To Buy Now Insider Monkey
Jan-20-21 11:36AM	Why You Should Retain Pacific Biosciences (PACB) Stock Now Zacks
07:50AM	ESG Stocks to Gather Speed Under Biden's Leadership: 5 Picks Zacks
Jan-19-21 09:16AM	Omnicell (OMCL) Reports Encouraging 2020 Preliminary Results Zacks
Jan-18-21 09:41AM	Intersect ENT's (XENT) Q4 Preliminary Revenues Disappointing Zacks
Jan-15-21 10:25AM	Masimo (MASI) Reports Encouraging 2020 Preliminary Results Zacks
08:35AM	Integra (IART) Preliminary Q4 Reported Sales Show Recovery Zacks
Jan-14-21 12:16PM	Exact Sciences (EXAS) Posts Solid Preliminary Q4 Testing Revenues Zacks
08:15AM	BD (BDX) Posts Upbeat Preliminary Fiscal First Quarter Results Zacks
07:20AM	Intuitive Surgical (ISRG) Up on Solid Preliminary Q4 Results Zacks
Jan-13-21 11:15AM	Pacific Biosciences (PACB) Releases Preliminary Q4 Revenues Zacks
09:45AM	Here's Why You Should Invest in McKesson (MCK) Stock Now Zacks
09:32AM	DexCom (DXCM) Posts Solid Preliminary Q4 and 2020 Revenues Zacks
05:54AM	Zacks.com featured highlights include: IDEXX Laboratories, AGCO, D.R. Horton and MSCI Zacks
Jan-12-21 11:41AM	Nevro (NVRO) Posts Weak Preliminary Q4 and 2020 Revenues Zacks
09:58AM	Phirbo (PAHC) Nutritional Specialty Aids Growth, Low ASP Ails Zacks
08:46AM	AMN Healthcare (AMN) Releases Solid Preliminary Q4 Revenues Zacks
07:41AM	4 of the Best Stocks to Buy for Solid Earnings Growth in 2021 Zacks
Jan-11-21 02:00PM	IDEXX Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results PR Newswire
09:48AM	Why You Must Add Merit Medical (MMSI) Stock to Your Portfolio Zacks
Jan-08-21 12:42PM	AngioDynamics (ANGO) Q2 Earnings and Revenues Top Estimates Zacks
Jan-07-21 11:25AM	Walgreens Boots (WBA) Q1 Earnings Top Estimates, Margins Down Zacks
09:03AM	Cardinal Health (CAH) Unveils New Logistics Management Tool Zacks
Jan-06-21 01:30PM	NEOGEN (NEOG) Fortifies Global Position via Megazyme Buyout Zacks
09:12AM	DENTSPLY (XRAY) Acquires Byte to Boost Clear Aligner Business Zacks
Jan-05-21 12:18PM	NextGen's (NXGN) Platform Gets Adopted by FPA Women's Health Zacks
12:00PM	Why You Should Retain Veeva (VEEV) in Your Portfolio Now? Zacks
Dec-31-20 09:39AM	Here's Why You Should Hold on to Illumina (ILMN) Stock for Now Zacks
Dec-30-20 09:57AM	Here's Why You Should Hold on to ResMed (RMD) Stock for Now Zacks
08:04AM	Teleflex (TFX) Completes Buyout of Hemostatic Goods Producer Zacks
Dec-29-20 11:25AM	Here's Why You Must Add Accuray (ARAY) to Your Portfolio Now Zacks
Dec-28-20 04:44PM	Dow Jones, Up 765 Points In December, Hits New Highs; When To Buy Microsoft Investor's Business Daily
12:18PM	Why You Must Add Merit Medical (MMSI) Stock to Your Portfolio Zacks
Dec-23-20 01:45PM	Here's Why You Should Retain Allscripts (MDRX) Stock for Now Zacks
11:30AM	Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? Zacks
10:59AM	8 Pet Stocks That Will Make You Purr InvestorPlace
Dec-22-20 01:48PM	Genmark Diagnostics Shows Market Leadership With Jump To 91 RS Rating Investor's Business Daily
Dec-21-20 08:50AM	IDEXX (IDXX) Gains on CAG Sales, Global Growth Remains Robust Zacks
Dec-18-20 11:30AM	4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2021 Zacks
Dec-15-20 10:29AM	The Zacks Analyst Blog Highlights: L Brands, The Trade Desk, IDEXX Laboratories, NVIDIA and CrowdStrike Zacks
10:21AM	Is IDXX A Good Stock To Buy Now? Insider Monkey
Dec-14-20 12:45PM	3 Reasons Why Idexx (IDXX) Is a Great Growth Stock Zacks
10:00AM	Top Ranked Growth Stocks to Buy for December 14th Zacks
09:16AM	Stimulus or No Stimulus, These Large Caps Are Must Buys Zacks
08:33AM	KalVista Pharmaceuticals (KALV) Catches Eye: Stock Jumps 7.4% Zacks
Dec-07-20 12:34PM	Is IDEXX Laboratories (IDXX) a Smart Long-term Buy? Insider Monkey
12:02PM	The Zacks Analyst Blog Highlights: Quest Diagnostics, Laboratory Corporation of America, Hologic, IDEXX Laboratories and Thermo Fisher Scientific Zacks
11:30AM	Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? Zacks
07:30AM	Are These Medical Stocks Cruising Toward Bullish Gains? Here's A Key Sign Investor's Business Daily
Nov-30-20 05:02PM	IBD 50 Stock Hologic Sees Relative Strength Rating Jump To 81 Investor's Business Daily
08:30AM	Why IDEXX Laboratories (IDXX) Could Be an Impressive Growth Stock Zacks
Nov-27-20 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX) Zacks
12:00PM	What Makes Idexx Laboratories (IDXX) a Strong Momentum Stock: Buy Now? Zacks
06:45AM	Pet Ownership Is Booming. Could These 3 Stocks Help You Profit? Motley Fool
Nov-26-20 12:20PM	Will Idexx (IDXX) Gain on Rising Earnings Estimates? Zacks
Nov-24-20 12:56PM	Zacks.com featured highlights include: CRMT, IDEXX, Best Buy and ParkerHannifin Zacks
Nov-20-20 11:30AM	Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? Zacks
08:12AM	4 of the Best Stocks That Boast Solid Earnings Growth Zacks
Nov-19-20 09:27AM	Zacks Industry Outlook Highlights: ResMed, Thermo Fisher Scientific, IDEXX Laboratories and STERIS Zacks
Nov-18-20 07:45AM	3 Best Buys from the Prospering Medical Instruments Industry Zacks
Nov-17-20 09:23AM	The Zacks Analyst Blog Highlights: Moderna, Lonza Group, BMW, NXP Semiconductors and IDEXX Laboratories Zacks
Nov-13-20 12:27PM	Should You Be Tempted To Sell IDEXX Laboratories (IDXX) Stock Insider Monkey
08:15AM	Why It Might Be Time To Pay Attention To These 4 Red-Hot Health Stocks Investor's Business Daily
Nov-12-20 07:30AM	IDEXX Laboratories Elects Dr. Asha S. Collins to Board of Directors PR Newswire
Nov-11-20 12:45PM	Looking for a Growth Stock? 3 Reasons Why Idexx (IDXX) is a Solid Choice Zacks
08:05AM	IDEXX Laboratories' (IDXX) Shares March Higher, Can It Continue? Zacks
Nov-04-20 04:39PM	Stock Upgrades: Dexcom Shows Rising Relative Strength Investor's Business Daily +5.69%

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JUNIUS DANIEL M	Director	Feb 22	Option Exercise	82.42	1,898	156,427	4,773	Feb 24 05:00 PM
Underberg Sharon E.	SVP, Gen. Counsel & Secretary	Feb 22	Option Exercise	206.94	483	99,952	1,878	Feb 24 05:01 PM
MAZELSKY JONATHAN JAY	President & CEO	Feb 22	Option Exercise	67.85	1,475	100,079	55,697	Feb 24 05:01 PM
JUNIUS DANIEL M	Director	Feb 22	Sale	538.57	1,898	1,022,207	2,875	Feb 24 05:00 PM
MCKEON BRIAN P	Executive VP & CFO	Feb 18	Option Exercise	67.85	1,474	100,011	26,188	Feb 19 05:01 PM
AYERS JONATHAN W	Director	Feb 18	Option Exercise	79.54	1,000	79,540	653,737	Feb 22 06:00 PM
AYERS JONATHAN W	Director	Feb 18	Sale	555.56	1,000	555,561	652,737	Feb 22 06:00 PM
MAZELSKY JONATHAN JAY	President & CEO	Feb 17	Option Exercise	52.00	25,000	1,300,000	68,090	Feb 19 05:00 PM
MAZELSKY JONATHAN JAY	President & CEO	Feb 17	Sale	537.21	13,868	7,449,969	54,222	Feb 19 05:00 PM
Claflin Bruce L.	Director	Feb 16	Option Exercise	97.05	7,027	681,985	7,331	Feb 18 07:26 PM
Claflin Bruce L.	Director	Feb 16	Sale	536.91	7,331	3,936,089	0	Feb 18 07:26 PM
Lane Michael	Executive Vice President	Feb 16	Sale	545.00	850	463,250	3,624	Feb 17 07:31 PM
MCKEON BRIAN P	Executive VP & CFO	Feb 16	Sale	539.58	1,307	705,231	24,714	Feb 17 07:33 PM
TWIGGE GIOVANI	Senior Vice President	Feb 14	Option Exercise	0.00	1,126	0	14,061	Feb 17 07:35 PM
MCKEON BRIAN P	Executive VP & CFO	Feb 14	Option Exercise	0.00	2,642	0	27,356	Feb 17 07:33 PM
POLEWACZYK JAMES F	Executive Vice President	Feb 14	Option Exercise	0.00	989	0	18,684	Feb 17 07:34 PM
Turner Kathy V	Senior Vice President	Feb 14	Option Exercise	0.00	987	0	11,142	Feb 17 07:34 PM
MAZELSKY JONATHAN JAY	President & CEO	Feb 14	Option Exercise	0.00	3,110	0	44,537	Feb 17 07:31 PM
Hunt Nimrata	Executive Vice President	Feb 14	Option Exercise	0.00	714	0	8,299	Feb 17 07:30 PM
Lane Michael	Executive Vice President	Feb 14	Option Exercise	0.00	984	0	4,768	Feb 17 07:31 PM
Underberg Sharon E.	SVP, Gen. Counsel & Secretary	Feb 14	Option Exercise	0.00	700	0	1,603	Feb 17 07:35 PM
Vandebroek Sophie V.	Director	Feb 12	Option Exercise	160.28	3,046	488,213	6,367	Feb 16 05:00 PM
Vandebroek Sophie V.	Director	Feb 12	Sale	538.20	3,046	1,639,357	3,321	Feb 16 05:00 PM
SZOSTAK M ANNE	Director	Feb 04	Option Exercise	74.78	11,876	888,128	11,876	Feb 08 06:05 PM
SZOSTAK M ANNE	Director	Feb 04	Sale	489.71	11,876	5,815,816	0	Feb 08 06:05 PM
TWIGGE GIOVANI	CORPORATE VICE PRESIDENT	Nov 30	Option Exercise	67.85	12,801	868,548	25,723	Dec 02 05:01 PM
TWIGGE GIOVANI	CORPORATE VICE PRESIDENT	Nov 30	Sale	456.49	12,801	5,843,566	12,922	Dec 02 05:01 PM
HENDERSON REBECCA M	Director	Nov 10	Option Exercise	85.00	5,902	501,670	20,598	Nov 12 05:01 PM
HENDERSON REBECCA M	Director	Nov 10	Sale	435.91	5,902	2,572,742	14,696	Nov 12 05:01 PM
MAZELSKY JONATHAN JAY	President & CEO	Nov 06	Option Exercise	69.68	2,868	199,846	41,413	Nov 09 05:01 PM
MCKEON BRIAN P	Executive VP & CFO	Nov 06	Sale	476.25	10,000	4,762,456	18,050	Nov 10 07:02 PM
AYERS JONATHAN W	Director	Nov 06	Sale	470.01	6,470	3,040,938	709,991	Nov 10 07:01 PM
MAZELSKY JONATHAN JAY	President & CEO	Nov 05	Sale	469.31	5,206	2,443,254	39,145	Nov 09 05:01 PM
Hunt Nimrata	Executive Vice President	Nov 05	Sale	470.08	2,098	986,228	7,571	Nov 06 05:07 PM
AYERS JONATHAN W	Director	Nov 05	Sale	467.16	15,134	7,069,988	716,461	Nov 06 05:06 PM
MCKEON BRIAN P	Executive VP & CFO	Nov 04	Option Exercise	79.54	36,216	2,880,621	60,916	Nov 06 05:07 PM
MCKEON BRIAN P	Executive VP & CFO	Nov 04	Sale	471.44	36,216	17,073,801	24,700	Nov 06 05:07 PM
AYERS JONATHAN W	Director	Nov 04	Sale	471.90	11,440	5,398,561	731,595	Nov 06 05:06 PM
Lane Michael	Executive Vice President	Nov 03	Option Exercise	70.92	2,851	202,184	5,074	Nov 05 07:51 PM
Lane Michael	Executive Vice President	Nov 03	Sale	443.00	1,304	577,670	3,770	Nov 05 07:51 PM
AYERS JONATHAN W	Director	Nov 03	Sale	443.63	10,432	4,627,955	743,035	Nov 04 05:25 PM
AYERS JONATHAN W	Director	Nov 02	Sale	433.01	10,000	4,330,085	753,467	Nov 04 05:25 PM
TWIGGE GIOVANI	CORPORATE VICE PRESIDENT	Aug 31	Option Exercise	69.95	7,316	511,775	20,222	Sep 02 05:00 PM
TWIGGE GIOVANI	CORPORATE VICE PRESIDENT	Aug 31	Sale	388.19	7,316	2,840,020	12,906	Sep 02 05:00 PM
TWIGGE GIOVANI	CORPORATE VICE PRESIDENT	Aug 28	Option Exercise	79.54	9,682	770,106	22,588	Aug 31 05:18 PM
TWIGGE GIOVANI	CORPORATE VICE PRESIDENT	Aug 28	Sale	384.11	9,682	3,718,990	12,906	Aug 31 05:18 PM
TWIGGE GIOVANI	CORPORATE VICE PRESIDENT	Aug 27	Option Exercise	79.54	8,356	664,636	21,262	Aug 31 05:18 PM
TWIGGE GIOVANI	CORPORATE VICE PRESIDENT	Aug 27	Sale	388.60	8,356	3,247,120	12,906	Aug 31 05:18 PM
AYERS JONATHAN W	Director	Aug 20	Option Exercise	67.85	18,000	1,221,300	828,467	Aug 24 05:05 PM
JUNIUS DANIEL M	Director	Aug 20	Option Exercise	63.95	3,722	238,022	6,569	Aug 21 05:00 PM
JUNIUS DANIEL M	Director	Aug 20	Sale	382.61	3,722	1,424,063	2,847	Aug 21 05:00 PM
AYERS JONATHAN W	Director	Aug 20	Sale	382.62	18,000	6,887,142	810,467	Aug 24 05:05 PM
Underberg Sharon E.	CVP, Gen. Counsel & Secretary	Aug 19	Option Exercise	206.94	483	99,952	874	Aug 20 05:01 PM
Hunt Nimrata	Executive Vice President	Aug 18	Option Exercise	72.37	1,805	130,629	9,652	Aug 18 05:09 PM
AYERS JONATHAN W	Director	Aug 18	Option Exercise	67.85	20,000	1,357,000	830,467	Aug 20 05:00 PM
MCKEON BRIAN P	Executive VP & CFO	Aug 18	Option Exercise	63.74	3,136	199,890	52,732	Aug 20 05:01 PM
AYERS JONATHAN W	Director	Aug 18	Sale	384.46	20,000	7,689,295	810,467	Aug 20 05:00 PM
Claflin Bruce L.	Director	Aug 18	Sale	385.11	5,629	2,167,803	304	Aug 18 05:09 PM
Claflin Bruce L.	Director	Aug 17	Option Exercise	70.54	5,629	397,070	5,933	Aug 18 05:09 PM
AYERS JONATHAN W	Director	Aug 17	Option Exercise	62.00	19,940	1,236,280	830,407	Aug 18 05:08 PM
AYERS JONATHAN W	Director	Aug 17	Sale	383.28	19,940	7,642,603	810,467	Aug 18 05:08 PM
AYERS JONATHAN W	Director	Aug 14	Option Exercise	62.00	25,000	1,550,000	835,467	Aug 18 05:08 PM
MCKEON BRIAN P	Executive VP & CFO	Aug 14	Option Exercise	56.09	83,724	4,696,331	133,320	Aug 18 05:10 PM
Hunt Nimrata	Executive Vice President	Aug 14	Sale	377.50	2,776	1,047,941	7,847	Aug 18 05:09 PM
AYERS JONATHAN W	Director	Aug 14	Sale	379.23	24,800	9,404,993	810,467	Aug 18 05:08 PM
MCKEON BRIAN P	Executive VP & CFO	Aug 14	Sale	378.97	83,724	31,729,072	49,596	Aug 18 05:10 PM
Claflin Bruce L.	Director	Aug 14	Sale	378.08	1,111	420,047	304	Aug 18 05:09 PM
MCKEON BRIAN P	EVP, CFO & Treasurer	Aug 05	Option Exercise	0.00	193	0	49,693	Aug 07 07:32 PM
MAZELSKY JONATHAN JAY	President and CEO	Aug 05	Option Exercise	0.00	385	0	44,512	Aug 07 07:12 PM
SZOSTAK M ANNE	Director	May 29	Option Exercise	63.95	7,722	493,822	7,722	Jun 02 05:00 PM
TWIGGE GIOVANI	CORPORATE VICE PRESIDENT	May 29	Option Exercise	63.57	14,070	894,370	26,962	Jun 02 05:01 PM
TWIGGE GIOVANI	CORPORATE VICE PRESIDENT	May 29	Sale	307.73	14,070	4,329,754	12,892	Jun 02 05:01 PM
SZOSTAK M ANNE	Director	May 29	Sale	306.91	7,722	2,369,921	0	Jun 02 05:00 PM
JUNIUS DANIEL M	Director	May 19	Option Exercise	63.95	4,000	255,800	6,834	May 20 05:01 PM
AYERS JONATHAN W	Director	May 19	Sale	294.99	10,000	2,949,900	10,000	May 20 05:00 PM
Turner Kathy V	Corporate Vice President	May 18	Sale	301.00	2,690	809,690	10,112	May 20 05:01 PM
AYERS JONATHAN W	Director	May 18	Sale	297.27	28,000	8,323,570	20,000	May 20 05:00 PM
HENDERSON REBECCA M	Director	May 13	Option Exercise	64.28	13,396	861,095	22,118	May 15 05:03 PM
HENDERSON REBECCA M	Director	May 13	Sale	286.66	13,396	3,840,052	14,696	May 15 05:03 PM
AYERS JONATHAN W	Director	May 12	Sale	293.41	30,000	8,802,300	48,000	May 13 05:02 PM
POLEWACZYK JAMES F	Executive Vice President	May 11	Option Exercise	74.54	16,264	1,212,260	28,882	May 12 05:15 PM
AYERS JONATHAN W	Director	May 11	Sale	297.80	20,000	5,956,000	78,000	May 13 05:02 PM
POLEWACZYK JAMES F	Executive Vice President	May 11	Sale	298.85	16,264	4,860,515	17,772	May 12 05:15 PM
AYERS JONATHAN W	Director	May 08	Option Exercise	62.00	21,130	1,310,060	831,597	May 12 05:11 PM
AYERS JONATHAN W	Director	May 08	Sale	291.63	21,130	6,162,059	810,467	May 12 05:11 PM
AYERS JONATHAN W	Director	May 07	Sale	292.25	11,000	3,214,750	98,000	May 08 05:00 PM
AYERS JONATHAN W	Director	May 06	Sale	286.07	13,600	3,890,552	109,000	May 08 05:00 PM
POLEWACZYK JAMES F	Executive Vice President	Feb 27	Option Exercise	79.54	1,256	99,902	17,749	Feb 28 05:00 PM
AYERS JONATHAN W	Director	Feb 25	Option Exercise	79.54	1,256	99,902	810,467	Feb 27 05:02 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience